Manufacturer
7 recalls in our database name C. O. Truxton as the manufacturing or recalling firm.
Of the 7 recalls from C. O. Truxton we have scored against our rubric, 1 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (14%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
C. O. Truxton is recalling Phenobarbital 15 mg tablets that were actually 30 mg due to a labeling error.
C. O. Truxton is recalling specific lots of Phenobarbital Tablets USP, 30 mg, because they may be mislabeled. The FDA classifies this as a Class I recall.
C. O. Truxton is recalling specific lots of Amitriptyline HCL 50 mg tablets due to potential label mixups. The recall is nationwide.
C. O. Truxton is recalling specific lots of Phenobarbital Tablets USP, 60 mg, due to a label mixup that may result in mislabeling.
C. O. Truxton is recalling Phenobarbital Tablets USP, 100 mg, due to a label mixup that may result in mislabeled products.
C. O. Truxton is recalling specific lots of Phenobarbital Tablets USP, 15 mg, due to a label mixup that may result in mislabeled products.
C. O. Truxton is recalling 287 bottles of Doxycycline Hyclate Tablets, 100 mg, because the product bears the wrong bar code.